Broad spectrum antiviral nucleosides-Our best hope for the future

被引：14

作者：

Seley-Radtke, Katherine L. ^{[1
]}

Thames, Joy E. ^{[1
]}

Waters, Charles D., III ^{[1
]}

机构：

[1] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA

来源：

CORONAVIRUSES AND OTHER NOVEL ANTIVIRAL TARGETS | 2021年 / 57卷

关键词：

HUMAN-IMMUNODEFICIENCY-VIRUS; POSITIVE CHRONIC HEPATITIS; B-E-ANTIGEN; ADEFOVIR DIPIVOXIL; REVERSE-TRANSCRIPTASE; DNA POLYMERASE; C VIRUS; INHIBITION; RIBAVIRIN; CIDOFOVIR;

D O I：

10.1016/bs.armc.2021.09.001

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：109 / 132

页数：24

共 123 条

[1] Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease [J].

Agostini, Maria L. ;

Andres, Erica L. ;

Sims, Amy C. ;

Graham, Rachel L. ;

Sheahan, Timothy P. ;

Lu, Xiaotao ;

Smith, Everett Clinton ;

Case, James Brett ;

Feng, Joy Y. ;

Jordan, Robert ;

Ray, Adrian S. ;

Cihlar, Tomas ;

Siegel, Dustin ;

Mackman, Richard L. ;

Clarke, Michael O. ;

Baric, Ralph S. ;

Denison, Mark R. .

MBIO, 2018, 9 (02)

[2] Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses [J].

Amirian, E. Susan ;

Levy, Julie K. .

ONE HEALTH, 2020, 9

[3]

Beasley D., 2021, REUTERS

[4] Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis [J].

Berliba, Elina ;

Bogus, Maxim ;

Vanhoutte, Frederic ;

Berghmans, Pieter-Jan ;

Good, Steven S. ;

Moussa, Adel ;

Pietropaolo, Keith ;

Murphy, Robert L. ;

Zhou, Xiao-Jian ;

Sommadossi, Jean-Pierre .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (12)

[5] Orally available cidofovir derivative active against smallpox [J].

Bradbury, J .

LANCET, 2002, 359 (9311) :1041-1041

[6] Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication [J].

Bravo, Jack P. K. ;

Dangerfield, Tyler L. ;

Taylor, David W. ;

Johnson, Kenneth A. .

MOLECULAR CELL, 2021, 81 (07) :1548-+

[7]

Cahard D, 2004, MINI-REV MED CHEM, V4, P371

[8] Treatment of hepatitis B e antigen - Positive chronic hepatitis with telbivudine or adefovir [J].

Chan, Henry L. Y. ;

Heathcote, E. Jenny ;

Marcellin, Patrick ;

Lai, Ching-Lung ;

Cho, Mong ;

Moon, Young M. ;

Chao, You-Chen ;

Myers, Robert P. ;

Minuk, Gerald Y. ;

Jeffers, Lennox ;

Sievert, William ;

Bzowej, Natalie ;

Harb, George ;

Kaiser, Ralf ;

Qiao, Xin-Jian ;

Brown, Nathaniel A. .

ANNALS OF INTERNAL MEDICINE, 2007, 147 (11) :745-U14

[9] An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia [J].

Charlton, Michael R. ;

Alam, Altaf ;

Shukla, Akash ;

Dashtseren, Bekhbold ;

Lesmana, Cosmas Rinaldi Adithya ;

Duger, Davadoorj ;

Payawal, Diana Alcantara ;

Duy Cuong, Do ;

Jargalsaikhan, Ganbolor ;

Cua, Ian Homer Yee ;

Sollano, Jose Decena ;

Singh, Karam Romeo ;

Madan, Kaushal ;

Win, Khin Maung ;

Kyi, Khin Pyone ;

Tun, Kyaw Soe ;

Salih, Mohd. ;

Rastogi, Mukul ;

Saraf, Neeraj ;

Thuy, Pham Thi Thu ;

Hien, Pham Tran Dieu ;

Gani, Rino Alvani ;

Mohamed, Rosmawati ;

Tanwandee, Tawesak ;

Piratvisuth, Teerha ;

Sukeepaisarnjaroen, Wattana ;

Naing, Win ;

Hashmi, Zahid Yasin .

JOURNAL OF GASTROENTEROLOGY, 2020, 55 (09) :811-823

[10] Development of cytarabine prodrugs and delivery systems for leukemia treatment [J].

Chhikara, Bhupender S. ;

Parang, Keykavous .

EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (12) :1399-1414

← 1 2 3 4 5 6 7 8 9 10 →